MabVax Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (2006)
Status: Acquired by Biontech (2019)

Organization Overview

First Clinical Trial
2010
NCT01141491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MabVax Therapeutic Holdings, Inc.